Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Dalbavancin - Second-Generation Glycopeptide



Evolution of new antibiotic classes

The evolution of new antibiotic classes from the 1930s to the present day.

  • Treatment of infections due to MRSA
    Antibiotics currently used in the treatment of infections due to MRSA.
  • Evolution of new antibiotic classes
    The evolution of new antibiotic classes from the 1930s to the present day.
  • Antibiotic resistance
    Antibiotic resistance is a growing problem and contributes to increased rates...
  • Classes of antibiotics
    Major classes of antibiotics used in the treatment of bacterial infections.
  • Skin and soft tissue infections
    Staphylococcus aureus is a major cause of skin and soft tissue...
  • Vicuron Pharmaceuticals
    Vicuron Pharmaceuticals' development pipeline.

Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Prexige - COX-2 Inhibitor
Prexige (lumiracoxib) is an innovative COX-2 inhibitor developed by...

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.